Goldman Sachs
NPTN

Goldman Sachs’s NEOPHOTONICS CORP NPTN Stock Holding History

Goldman Sachs’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,689,218
Closed -$26.6M – 6840
2022
Q2 		$26.6M Buy
1,689,218
+255,456
+18% +$3.9M 0.01% 1661
2022
Q1 		$21.8M Buy
1,433,762
+698,281
+95% +$10.6M ﹤0.01% 1987
2021
Q4 		$11.3M Buy
735,481
+517,533
+237% +$6.81M ﹤0.01% 2648
2021
Q3 		$1.9M Buy
217,948
+107,036
+97% +$976K ﹤0.01% 4250
2021
Q2 		$1.13M Sell
110,912
-283,962
-72% -$3M ﹤0.01% 4671
2021
Q1 		$4.72M Sell
394,874
-929,625
-70% -$10.5M ﹤0.01% 3192
2020
Q4 		$12M Buy
1,324,499
+16,625
+1% +$129K ﹤0.01% 2291
2020
Q3 		$7.96M Buy
1,307,874
+242,190
+23% +$1.85M ﹤0.01% 2516
2020
Q2 		$9.46M Buy
1,065,684
+769,274
+260% +$6.63M ﹤0.01% 2321
2020
Q1 		$2.15M Sell
296,410
-307,607
-51% -$2.28M ﹤0.01% 3244
2019
Q4 		$5.33M Buy
604,017
+187,024
+45% +$1.4M ﹤0.01% 2910
2019
Q3 		$2.54M Buy
416,993
+321,809
+338% +$1.81M ﹤0.01% 3381
2019
Q2 		$398K Sell
95,184
-694
-0.7% -$3.66K ﹤0.01% 4487
2019
Q1 		$603K Buy
95,878
+53,650
+127% +$376K ﹤0.01% 4328
2018
Q4 		$273K Sell
42,228
-22,107
-34% -$169K ﹤0.01% 4683
2018
Q3 		$534K Buy
64,335
+47,471
+281% +$361K ﹤0.01% 4391
2018
Q2 		$105K Sell
16,864
-116,358
-87% -$740K ﹤0.01% 5199
2018
Q1 		$913K Buy
133,222
+30,960
+30% +$197K ﹤0.01% 4114
2017
Q4 		$673K Sell
102,262
-38,687
-27% -$236K ﹤0.01% 4593
2017
Q3 		$783K Buy
140,949
+43,950
+45% +$297K ﹤0.01% 4785
2017
Q2 		$749K Buy
96,999
+433
+0.4% +$3.66K ﹤0.01% 4729
2017
Q1 		$870K Buy
96,566
+81,750
+552% +$852K ﹤0.01% 4507
2016
Q4 		$160K Sell
14,816
-626,699
-98% -$8.36M ﹤0.01% 5917
2016
Q3 		$10.5M Buy
641,515
+624,901
+3,761% +$8.79M ﹤0.01% 2413
2016
Q2 		$158K Sell
16,614
-1,758
-10% -$19.1K ﹤0.01% 5858
2016
Q1 		$258K Buy
18,372
+5,596
+44% +$57.9K ﹤0.01% 5389
2015
Q4 		$139K Sell
12,776
-5,575
-30% -$50.4K ﹤0.01% 5976
2015
Q3 		$125K Sell
18,351
-12,274
-40% -$95K ﹤0.01% 6340
2015
Q2 		$280K Sell
30,625
-8,429
-22% -$63.9K ﹤0.01% 5804
2015
Q1 		$264K Buy
39,054
+10,409
+36% +$41.9K ﹤0.01% 5761
2014
Q4 		$97K Sell
28,645
-6,593
-19% -$21.1K ﹤0.01% 6582
2014
Q3 		$118K Buy
35,238
+6,604
+23% +$20.6K ﹤0.01% 6504
2014
Q2 		$119K Buy
28,634
+9,112
+47% +$48.2K ﹤0.01% 6485
2014
Q1 		$155K Buy
19,522
+2,576
+15% +$19.2K ﹤0.01% 6223
2013
Q4 		$120K Buy
16,946
+4,721
+39% +$31.5K ﹤0.01% 6206
2013
Q3 		$90K Buy
+12,225
New +$95.1K ﹤0.01% 6183

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Goldman Sachs's NPTN Position: Q3 2022 in Review

Goldman Sachs sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 1,689,218 shares — an estimated $26.6M sold.

Goldman Sachs first reported a position in NPTN in Q3 2013 and held it in 36 quarters. The position peaked at $26.6M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Goldman Sachs reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 1,689,218 NEOPHOTONICS CORP shares in Q3 2022, an estimated $26.6M.
  • Goldman Sachs first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 36 quarters.
  • Goldman Sachs's NEOPHOTONICS CORP position peaked at $26.6M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.